SCHEMBL5044931

SCHEMBL5044931

Cc1cc(-c2ccc(Cl)cc2)nc2c(C(=O)Nc3cccc(S(=O)(=O)NC(C)(C)CO)c3)cnn12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF18A Q8NI77 7/20 0.52
KDM4E B2RXH2 4/20 0.46
POLB P06746 3/20 0.46
TP53 P04637 2/20 0.46
MAPK1 P28482 1/20 0.45
KMT2A Q03164 2/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 2/20 0.45
GBA1 P04062 1/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGD P15428 2/20 0.42
CYP1A1 P04798 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5048260 0.91 KIF18A (0.51) KIF18AKDM4EPOLBTP53MAPK1
SCHEMBL5050002 0.90 KIF18A (0.51) KIF18AKDM4EPOLBTP53MAPK1
SCHEMBL5046611 0.90 MAPK1 (0.58) KIF18AKDM4EPOLBTP53MAPK1
SCHEMBL5041480 0.89 KIF18A (0.50) KIF18AKDM4EPOLBTP53MAPK1
SCHEMBL5044973 0.89 KIF18A (0.50) KIF18AKDM4EPOLBTP53MAPK1
SCHEMBL5039327 0.87 KIF18A (0.47) KIF18AKDM4EMAPK1KMT2AHTT
SCHEMBL5045481 0.86 ALDH1A1 (0.51) KDM4EPOLBTP53MAPK1KMT2A
SCHEMBL5041944 0.85 CA2 (0.59) KDM4EPOLBTP53MAPK1KMT2A
SCHEMBL5036356 0.83 KIF18A (0.54) KIF18AKDM4EPOLBTP53MAPK1
SCHEMBL5040794 0.83 THRB (0.47) KIF18AKDM4EPOLBMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378417-B2 Pyrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US claimed
US-20050282827-A1 Pyrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 US claimed
US-7378417-B2 Pyrazolo-pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-27 US disclosed
US-20050282827-A1 Pyrazolo-pyrimidine derivatives F. HOFFMANN-LA ROCHE AG (CH) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282827-A1 Pyrazolo-pyrimidine derivatives P2RX3, P2RX1, P2RX5 KIF18A 2868/4885KDM4E 3638/4885POLB 2158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.